Key result
In patients with end-stage chronic kidney disease, a lower retinal artery wall-to-lumen ratio was associated with an increased 3-year risk of death or cardiovascular events.
Why the study?
The prognostic value of the wall-to-lumen ratio of retinal arteries for morbidity and mortality in patients with end-stage chronic kidney disease was not established.
Does the wall-to-lumen ratio of retinal arteries predict death or cardiovascular events in patients with end-stage chronic kidney disease?
Cohort (n=83)
No
Does the wall-to-lumen ratio of retinal arteries predict death or cardiovascular events in patients with end-stage chronic kidney disease?
Answers are grounded in this paper and cite their sources.
In patients with end-stage CKD, a lower wall-to-lumen ratio of retinal arteries is associated with a higher 3-year risk of death or cardiovascular events, suggesting its potential as a novel prognostic biomarker.
PURPOSE: To investigate the hypothesis that the wall-to-lumen ratio (WLR) of retinal arteries is predictive of morbidity and mortality in patients with end-stage chronic kidney disease (CKD). METHODS: Prospective single center clinical study. In 83 patients with CKD (average age (±SD) 75.8 (±11.4) years), arterial metrics in the retinal vasculature were measured using adaptive optics ophthalmoscopy (AOO; rtx1, ImagineEyes, France). Multivariate analysis including vascular metrics and biological parameters was done to identify predictive risk factors of the morbidity and mortality rates at 3 years. RESULTS: At inclusion, the mean (±SD) wall-to-lumen ratio (WLR) was 0,34 (± 0,17). No correlation was found between blood pressure and the WLR. The 1, 2 and 3-year survival rates were 74.7 %, 57.3 % and 42.1 %, respectively. The 1, 2 and 3-year rates of nonfatal cardiovascular events were 25.3 %, 42.7 % and 56.5 %, respectively. Four patients were lost to follow-up. Based on a Cox model, the cumulative 3-year relative risk of death or cardiovascular event was inversely correlated to the initial WLR (RR 2.5 if WLR <0.36, 2.1 if <0.3, 4.9 if <0.27), age over 80 years (RR 1.9), and sedentarity (RR 2.3). Metabolic factors were not predictive of event-free survival. CONCLUSIONS: In patients with end-stage CKD, a lower WLR is associated with a higher morbidity and mortality rate at 3 years. Retinal vascular metrics may therefore provide novel biomarkers for the prediction of event-free survival in CKD. Additional studies are necessary to elucidate the underlying relationship.
No takes yet. Share an insight, caveat, or question.
Faure et al. (2025) conducted a cohort in end-stage chronic kidney disease (n=83). Lower wall-to-lumen ratio (WLR) of retinal arteries vs. Higher wall-to-lumen ratio was evaluated on death or cardiovascular event at 3 years (RR 4.9). In patients with end-stage chronic kidney disease, a lower retinal artery wall-to-lumen ratio was associated with an increased 3-year risk of death or cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: